Drug factory · FDA FEI 3002807776
Sterling Pharma Ringaskiddy LIMITED
Ringaskiddy, Co Cork, Ireland
Problems found, fixed voluntarily at FDA's last inspection, Apr 5, 2022.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
6 drug inspections on record since 2008: 4 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Pasireotide | Makes the active ingredient and tests it | Recordati Rare Diseases, Inc. | 55292-131, 55292-132, 55292-133 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Apr 5, 2022 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 13, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 3, 2017 | No problems found | Drug Quality Assurance | — |
| Mar 28, 2014 | No problems found | Drug Quality Assurance | — |
| Sep 22, 2010 | No problems found | Drug Quality Assurance | — |
| Oct 15, 2008 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.